Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 115 Pages
Report ld: 5779248
Request Sample
Customized Report
Human NK Cell Isolation Kit Market Size(US$)

CAGR 2026-2032
6.5%
Market Size,2032
USD 497
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 322 million in 2025 and is projected to reach US$ 497 million, growing at a CAGR of 6.5% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Human NK Cell Isolation Kit cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The Human NK Cell Isolation Kit is designed to magnetically isolate NK cells from a complex immune cell population. The kit is optimized for the isolation of CD56+CD3- cells from normal human peripheral blood mononuclear cells (PBMCs). The cells are incubated with a cocktail of antibodies and then bound to magnetic beads. They are then placed on a magnet for quick and easy separation. When placed on the magnet, non-NK cells will be fixed to the side of the tube, while NK cells will remain in suspension and can be easily removed for downstream applications.
The North American market for Human NK Cell Isolation Kit was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Human NK Cell Isolation Kit was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Human NK Cell Isolation Kit was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Human NK Cell Isolation Kit market include BPS Bioscience, Miltenyi Biotec, Novus Biologicals, STEMCELL Technologies, Thermo Fisher Scientific, RWD, Xinxie Biotechnology, Jinzhun Biotechnology, R&D Systems, BioLegend, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Human NK Cell Isolation Kit, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Human NK Cell Isolation Kit market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Human NK Cell Isolation Kit.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Human NK Cell Isolation Kit manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Human NK Cell Isolation Kit sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Human NK Cell Isolation Kit sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human NK Cell Isolation Kit Product Introduction
1.2 Global Human NK Cell Isolation Kit Market Size Forecast
1.2.1 Global Human NK Cell Isolation Kit Sales Value (2021–2032)
1.2.2 Global Human NK Cell Isolation Kit Sales Volume (2021–2032)
1.2.3 Global Human NK Cell Isolation Kit Sales Price (2021–2032)
1.3 Human NK Cell Isolation Kit Market Trends & Drivers
1.3.1 Human NK Cell Isolation Kit Industry Trends
1.3.2 Human NK Cell Isolation Kit Market Drivers & Opportunities
1.3.3 Human NK Cell Isolation Kit Market Challenges
1.3.4 Human NK Cell Isolation Kit Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human NK Cell Isolation Kit Players Revenue Ranking (2025)
2.2 Global Human NK Cell Isolation Kit Revenue by Company (2021–2026)
2.3 Global Human NK Cell Isolation Kit Sales Volume Ranking of Players (2025)
2.4 Global Human NK Cell Isolation Kit Sales Volume by Company (2021–2026)
2.5 Global Human NK Cell Isolation Kit Average Price by Company (2021–2026)
2.6 Key Manufacturers Human NK Cell Isolation Kit Manufacturing Base and Headquarters
2.7 Key Manufacturers Human NK Cell Isolation Kit Product Offerings
2.8 Key Manufacturers Start of Mass Production of Human NK Cell Isolation Kit
2.9 Human NK Cell Isolation Kit Market Competitive Analysis
2.9.1 Human NK Cell Isolation Kit Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Human NK Cell Isolation Kit Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human NK Cell Isolation Kit revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Human NK Cell Isolation Kit Market Classification
3.1 Introduction by Type
3.1.1 1 x 10^8 Cells
3.1.2 1 x 10^9 Cells
3.1.3 Other
3.1.4 Global Human NK Cell Isolation Kit Sales Value by Type
3.1.4.1 Global Human NK Cell Isolation Kit Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Human NK Cell Isolation Kit Sales Value, by Type (2021–2032)
3.1.4.3 Global Human NK Cell Isolation Kit Sales Value, by Type (%), 2021–2032
3.1.5 Global Human NK Cell Isolation Kit Sales Volume by Type
3.1.5.1 Global Human NK Cell Isolation Kit Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Human NK Cell Isolation Kit Sales Volume, by Type (2021–2032)
3.1.5.3 Global Human NK Cell Isolation Kit Sales Volume, by Type (%), 2021–2032
3.1.6 Global Human NK Cell Isolation Kit Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institute
4.1.2 School
4.1.3 Other
4.2 Global Human NK Cell Isolation Kit Sales Value by Application
4.2.1 Global Human NK Cell Isolation Kit Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Human NK Cell Isolation Kit Sales Value, by Application (2021–2032)
4.2.3 Global Human NK Cell Isolation Kit Sales Value, by Application (%), 2021–2032
4.3 Global Human NK Cell Isolation Kit Sales Volume by Application
4.3.1 Global Human NK Cell Isolation Kit Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Human NK Cell Isolation Kit Sales Volume, by Application (2021–2032)
4.3.3 Global Human NK Cell Isolation Kit Sales Volume, by Application (%), 2021–2032
4.4 Global Human NK Cell Isolation Kit Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Human NK Cell Isolation Kit Sales Value by Region
5.1.1 Global Human NK Cell Isolation Kit Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Human NK Cell Isolation Kit Sales Value by Region (2021–2026)
5.1.3 Global Human NK Cell Isolation Kit Sales Value by Region (2027–2032)
5.1.4 Global Human NK Cell Isolation Kit Sales Value by Region (%), 2021–2032
5.2 Global Human NK Cell Isolation Kit Sales Volume by Region
5.2.1 Global Human NK Cell Isolation Kit Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Human NK Cell Isolation Kit Sales Volume by Region (2021–2026)
5.2.3 Global Human NK Cell Isolation Kit Sales Volume by Region (2027–2032)
5.2.4 Global Human NK Cell Isolation Kit Sales Volume by Region (%), 2021–2032
5.3 Global Human NK Cell Isolation Kit Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Human NK Cell Isolation Kit Sales Value, 2021–2032
5.4.2 North America Human NK Cell Isolation Kit Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Human NK Cell Isolation Kit Sales Value, 2021–2032
5.5.2 Europe Human NK Cell Isolation Kit Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Human NK Cell Isolation Kit Sales Value, 2021–2032
5.6.2 Asia Pacific Human NK Cell Isolation Kit Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Human NK Cell Isolation Kit Sales Value, 2021–2032
5.7.2 South America Human NK Cell Isolation Kit Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human NK Cell Isolation Kit Sales Value, 2021–2032
5.8.2 Middle East & Africa Human NK Cell Isolation Kit Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human NK Cell Isolation Kit Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Human NK Cell Isolation Kit Sales Value and Sales Volume
6.2.1 Key Countries/Regions Human NK Cell Isolation Kit Sales Value, 2021–2032
6.2.2 Key Countries/Regions Human NK Cell Isolation Kit Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Human NK Cell Isolation Kit Sales Value, 2021–2032
6.3.2 United States Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Human NK Cell Isolation Kit Sales Value, 2021–2032
6.4.2 Europe Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Human NK Cell Isolation Kit Sales Value, 2021–2032
6.5.2 China Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.5.3 China Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Human NK Cell Isolation Kit Sales Value, 2021–2032
6.6.2 Japan Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Human NK Cell Isolation Kit Sales Value, 2021–2032
6.7.2 South Korea Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Human NK Cell Isolation Kit Sales Value, 2021–2032
6.8.2 Southeast Asia Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Human NK Cell Isolation Kit Sales Value, 2021–2032
6.9.2 India Human NK Cell Isolation Kit Sales Value by Type (%), 2025 vs 2032
6.9.3 India Human NK Cell Isolation Kit Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BPS Bioscience
7.1.1 BPS Bioscience Company Information
7.1.2 BPS Bioscience Introduction and Business Overview
7.1.3 BPS Bioscience Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BPS Bioscience Human NK Cell Isolation Kit Product Offerings
7.1.5 BPS Bioscience Recent Developments
7.2 Miltenyi Biotec
7.2.1 Miltenyi Biotec Company Information
7.2.2 Miltenyi Biotec Introduction and Business Overview
7.2.3 Miltenyi Biotec Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Miltenyi Biotec Human NK Cell Isolation Kit Product Offerings
7.2.5 Miltenyi Biotec Recent Developments
7.3 Novus Biologicals
7.3.1 Novus Biologicals Company Information
7.3.2 Novus Biologicals Introduction and Business Overview
7.3.3 Novus Biologicals Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Novus Biologicals Human NK Cell Isolation Kit Product Offerings
7.3.5 Novus Biologicals Recent Developments
7.4 STEMCELL Technologies
7.4.1 STEMCELL Technologies Company Information
7.4.2 STEMCELL Technologies Introduction and Business Overview
7.4.3 STEMCELL Technologies Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 STEMCELL Technologies Human NK Cell Isolation Kit Product Offerings
7.4.5 STEMCELL Technologies Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Information
7.5.2 Thermo Fisher Scientific Introduction and Business Overview
7.5.3 Thermo Fisher Scientific Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Thermo Fisher Scientific Human NK Cell Isolation Kit Product Offerings
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 RWD
7.6.1 RWD Company Information
7.6.2 RWD Introduction and Business Overview
7.6.3 RWD Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 RWD Human NK Cell Isolation Kit Product Offerings
7.6.5 RWD Recent Developments
7.7 Xinxie Biotechnology
7.7.1 Xinxie Biotechnology Company Information
7.7.2 Xinxie Biotechnology Introduction and Business Overview
7.7.3 Xinxie Biotechnology Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Xinxie Biotechnology Human NK Cell Isolation Kit Product Offerings
7.7.5 Xinxie Biotechnology Recent Developments
7.8 Jinzhun Biotechnology
7.8.1 Jinzhun Biotechnology Company Information
7.8.2 Jinzhun Biotechnology Introduction and Business Overview
7.8.3 Jinzhun Biotechnology Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Jinzhun Biotechnology Human NK Cell Isolation Kit Product Offerings
7.8.5 Jinzhun Biotechnology Recent Developments
7.9 R&D Systems
7.9.1 R&D Systems Company Information
7.9.2 R&D Systems Introduction and Business Overview
7.9.3 R&D Systems Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 R&D Systems Human NK Cell Isolation Kit Product Offerings
7.9.5 R&D Systems Recent Developments
7.10 BioLegend
7.10.1 BioLegend Company Information
7.10.2 BioLegend Introduction and Business Overview
7.10.3 BioLegend Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 BioLegend Human NK Cell Isolation Kit Product Offerings
7.10.5 BioLegend Recent Developments
7.11 Proteintech Group
7.11.1 Proteintech Group Company Information
7.11.2 Proteintech Group Introduction and Business Overview
7.11.3 Proteintech Group Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Proteintech Group Human NK Cell Isolation Kit Product Offerings
7.11.5 Proteintech Group Recent Developments
7.12 Stemery
7.12.1 Stemery Company Information
7.12.2 Stemery Introduction and Business Overview
7.12.3 Stemery Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Stemery Human NK Cell Isolation Kit Product Offerings
7.12.5 Stemery Recent Developments
7.13 Creative Bioarray
7.13.1 Creative Bioarray Company Information
7.13.2 Creative Bioarray Introduction and Business Overview
7.13.3 Creative Bioarray Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Creative Bioarray Human NK Cell Isolation Kit Product Offerings
7.13.5 Creative Bioarray Recent Developments
7.14 LubioScience
7.14.1 LubioScience Company Information
7.14.2 LubioScience Introduction and Business Overview
7.14.3 LubioScience Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 LubioScience Human NK Cell Isolation Kit Product Offerings
7.14.5 LubioScience Recent Developments
7.15 Immocell
7.15.1 Immocell Company Information
7.15.2 Immocell Introduction and Business Overview
7.15.3 Immocell Human NK Cell Isolation Kit Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Immocell Human NK Cell Isolation Kit Product Offerings
7.15.5 Immocell Recent Developments
8 Industry Chain Analysis
8.1 Human NK Cell Isolation Kit Industrial Chain
8.2 Human NK Cell Isolation Kit Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Human NK Cell Isolation Kit Sales Model
8.5.2 Sales Channels
8.5.3 Human NK Cell Isolation Kit Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 91
USD 4250.00
(Single User License)
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 121
USD 2900.00
(Single User License)
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 153
USD 4900.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 140
USD 4350.00
(Single User License)
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published Date: 2025-01-01
Pages: 161
USD 4900.00
(Single User License)
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 111
USD 3950.00
(Single User License)
The global Human NK Cell Isolation Kit market is projected to grow from US$ 322 million in 2025 to US$ 497 million by 2032, at a CAGR of 6.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Human NK Cell Isolation Kit market size was US$ 322 million in 2025 and is forecast to reach a readjusted size of US$ 497 million by 2032 with a CAGR of 6.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 91
The global Human NK Cell Isolation Kit market was valued at US$ 322 million in 2025 and is anticipated to reach US$ 497 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 121
The global Human NK Cell Isolation Kit market size was US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
The global Human NK Cell Isolation Kit market is projected to grow from US$ 304 million in 2024 to US$ 470 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 153
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 304 million in 2024 and is forecast to a readjusted size of US$ 470 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
The global market for Human NK Cell Isolation Kit was valued at US$ 304 million in the year 2024 and is projected to reach a revised size of US$ 470 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-03-10
Pages: 97
The global Human NK Cell Isolation Kit revenue was US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the review period (2024-2030).
Published: 2025-01-01
Pages: 140
Valued at US$ 304 million in 2024, the global Human NK Cell Isolation Kit market is forecast to reach US$ 444 million by 2030, at a CAGR of 6.5% during the forecast period.
Published: 2025-01-01
Pages: 161
The global market for Human NK Cell Isolation Kit was estimated to be worth US$ 282 million in 2023 and is forecast to a readjusted size of US$ 444 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 111
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now